STEPS Trial - Spheramine Safety and Efficacy Study

Clinical trial NCT00206687 · TERMINATED

Trial details

NCT number: NCT00206687
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2003-01-08
Primary completion: 2012-05-14
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.